TRIAL OF PREEMIE SMA SUPPLEMENTED WITH LONG CHAIN POLYUNSATURATED FATTY ACIDS

本研究的主要目的是评价龙的安全性。 链状多不饱和脂肪酸补充早产儿SMA早产 婴儿。本研究是一项双盲、随机、对照、多因素研究。 中心前瞻性研究。患者既是住院患者，也是 门诊部。 自上次批准以来，我们共招募了5名患者 完成了研究方案的住院阶段。这些病人 继续作为门诊患者进行研究并完成他们的参与 在截至1997年3月的研究中，在其12个月的评估中。 我们没有遇到与抽血有关的并发症，也没有 注意到任何对任何研究配方的喂养不耐受的迹象。全 五名患者的参数在以下范围内适当增长 增长图表的25%和75%，修正了早产儿。

The primary objective of this study is to evaluate the safety of long chain polyunsaturated fatty acid (LCP) supplemented preemie SMA in preterm infants. This study is a double-blind, randomized, controlled, multi- center prospective study. Patients were studied as both inpatients and outpatients. Since the last approval, we have enrolled a total of 5 patients who completed the in-hospital phase of the study protocol. These patients continued to be studied as outpatients and completed their participation in the study as of March 1997, at their 12 month evaluation. We have encountered no complications related to blood drawing and have not noticed any signs of feeding intolerance to any of the study formulas. All five patients are growing appropriately with parameters falling within the 25 and 75 percentiles of the growth chart, corrected for prematurity.